The Influence of Apolipoprotein E Genotype on Visuospatial Attention Dissipates After Age 80

Neuropsychology

Volumn 23, Issue 1, 2009, Pages 81-89

  Negash, Selam ^a   Greenwood, Pamela M ^b   Sunderland, Trey ^c   Parasuraman, Raja ^b   Geda, Yonas E ^a   Knopman, David S ^a   Boeve, Bradley F ^a   Ivnik, Robert J ^a   Petersen, Ronald C ^a   Smith, Glenn E ^a  

^a MAYO CLINIC   (United States)

^b GEORGE MASON UNIVERSITY   (United States)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

APOE; attention; old old; phenotype

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E4; BIOLOGICAL MARKER;

ADULT; AGED; AGING; ALZHEIMER DISEASE; ARTICLE; ATTENTION; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DEPTH PERCEPTION; DISEASE MARKER; FEMALE; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOSITY; HETEROZYGOTE; HUMAN; MALE; PREDICTION; PRIORITY JOURNAL; REACTION TIME; SPATIAL DISCRIMINATION; TASK PERFORMANCE;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; AGING; APOLIPOPROTEIN E4; ATTENTION; DISCRIMINATION (PSYCHOLOGY); FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PHOTIC STIMULATION; REACTION TIME; SPACE PERCEPTION;

EID: 58749102624     PISSN: 08944105     EISSN: None     Source Type: Journal    
DOI: 10.1037/a0014014     Document Type: Article

References (57)

1. Backman L., Laukka E.J., Wahlin A., Small B.J., and Fratiglioni L. Influences of preclinical dementia and impending death on the magnitude of age-related cognitive deficits. Psychology and Aging 17 (2002) 435-442
2. Bartus R.T., Dean III R.L., Beer B., and Lippa A.S. The cholinergic hypothesis of geriatric memory dysfunction. Science 217 (1982) 408-414
3. Bennet A.M., Di Angelatonio E., Ye Z., Wensley F., Dahlin A., Ahlbom A., et al. Association of apolipoprotein E genotypes with lipid levels and coronary risk. Journal of the American Medical Association 298 (2007) 1300-1311
4. Bondi M.W., Salmon D.P., Monsch A.U., Galasko D., Butters N., Klauber M.R., et al. Episodic memory changes are associated with the APOE-e4 allele in nondemented older adults. Neurology 45 (1995) 2203-2206
5. Breitner J.C., Wyse B.W., Anthony J.C., Welsh-Bohmer K.A., Steffens D.C., Norton M.C., et al. APOE-epsilon4 count predicts age when prevalence of AD increases, then declines: The Cache County Study. Neurology 53 (1999) 321-331
6. Bretsky P., Guralnik J.M., Launer L., Albert M., and Seeman T.E. The role of APOE-epsilon4 in longitudinal cognitive decline: MacArthur Studies of Successful Aging. Neurology 60 (2003) 1077-1081
7. Buschke H. Selective reminding for analysis of memory and learning. Journal of Verbal Learning and Verbal Behavior 12 (1973) 543-550
8. Cohen R.M., Carson R.E., Filbey F., Szczepanik J., and Sunderland T. Age and APOE-epsilon4 genotype influence the effect of physostigmine infusion on the in-vivo distribution volume of the muscarinic-2-receptor dependent tracer [18F]FP-TZTP. Synapse 60 (2006) 86-92
9. Cohen R.M., Podruchny T.A., Bokde A.L., Carson R.E., Herscovitch P., Kiesewetter D.O., et al. Higher in vivo muscarinic-2 receptor distribution volumes in aging subjects with an apolipoprotein E-epsilon4 allele. Synapse 49 (2003) 150-156
10. Cohen R.M., Small C., Lalonde F., Friz J., and Sunderland T. Effect of apolipoprotein E genotype on hippocampal volume loss in aging healthy women. Neurology 57 (2001) 2223-2228
11. Conner J.M., Chiba A.A., and Tuszynski M.H. The basal forebrain cholinergic system is essential for cortical plasticity and functional recovery following brain injury. Neuron 46 (2005) 173-179
12. Corbetta M., Kincade J.M., Ollinger J.M., McAvoy M.P., and Shulman G.L. Voluntary orienting is dissociated from target detection in human posterior parietal cortex. Nature Neuroscience 3 (2000) 292-297
13. Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D., Gaskell P., Small W., et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261 (1993) 921-923
14. Davidson M.C., and Marrocco R.T. Local infusion of scopolamine into intraparietal cortex slows covert orienting in rhesus monkeys. Journal of Neurophysiology 83 (2000) 1536-1549
15. Donnai D., and Karmiloff-Smith A. Williams syndrome: From genotype through to the cognitive phenotype. American Journal of Medicine Genet 97 (2000) 164-171
16. Drory V.E., Birnbaum M., Korczyn A.D., and Chapman J. Association of APOE epsilon4 allele with survival in amyotrophic lateral sclerosis. Journal of Neurology Science 190 (2001) 17-20
17. Espeseth T., Greenwood P.M., Reinvang I., Fjell A.M., Walhovd K.B., Westlye L.T., et al. Interactive effects of APOE and CHRNA4 on attention and white matter volume in healthy middle-aged and older adults. Cognitive, Affective & Behavioral Neuroscience 6 (2006) 31-43
18. Fazekas F., Strasser-Fuchs S., Kollegger H., Berger T., Kristoferitsch W., Schmidt H., et al. Apolipoprotein E epsilon 4 is associated with rapid progression of multiple sclerosis. Neurology 57 (2001) 853-857
19. Feskens E.J.M., Havekes L.M., Kalmijn S., Knijff P.D., Launer L.J., and Kromhout D. Apolipoprotein e4 allele and cognitive decline in elderly men. British Journal of Medicine 309 (1994) 1202-1206
20. Flory J.D., Manuck S.B., Ferrell R.E., Ryan C.M., and Muldoon M.F. Memory performance and the apolipoprotein E polymorphism in a community sample of middle-aged adults. American Journal of Medical Genetics 96 (2000) 707-711
21. Gallagher M., and Colombo P.J. Ageing: The cholinergic hypothesis of cognitive decline. Current Opinion in Neurobiology 5 (1995) 161-168
22. Greenwood P., Parasuraman R., and Haxby J. Changes in visuospatial attention over the adult lifespan. Neuropsychologia 31 (1993) 471-485
23. Greenwood P.M., Lambert C., Sunderland T., and Parasuraman R. Effects of apolipoprotein E genotype on spatial attention, working memory, and their interaction in healthy, middle-aged adults: Results from the National Institute of Mental Health's BIOCARD study. Neuropsychology 19 (2005) 199-211
24. Greenwood P.M., and Parasuraman R. Normal genetic variation, cognition, and aging. Behavioral and Cognitive Neuroscience Reviews 2 (2003) 278-306
25. Greenwood P.M., and Parasuraman R. The scaling of spatial attention in visual search and its modification in healthy aging. Perception & Psychophysics 66 (2004) 3-22
26. Greenwood P.M., Parasuraman R., and Alexander G.E. Controlling the focus of spatial attention during visual search: effects of advanced aging and Alzheimer disease. Neuropsychology 11 1 (1997) 3-12
27. Greenwood P.M., Sunderland T., Friz J.L., and Parasuraman R. Genetics and visual attention: Selective deficits in healthy adult carriers of the varepsilon 4 allele of the apolipoprotein E gene. Proceedings of the National Academy of Sciences of the United States of America 97 (2000) 11661-11666
28. Greenwood P.M., Sunderland T., Putnam K., Levy J., and Parasuraman R. Scaling of visuospatial attention undergoes differential longitudinal change as a function of APOE genotype prior to old age: Results from the NIMH BIOCARD Study. Neuropsychology 19 (2005) 830-840
29. Hayden K.M., Zandi P.P., Lyketsos C.G., Tschanz J.T., Norton M.C., Khachaturian A.S., et al. Apolipoprotein E genotype and mortality: Findings from the Cache County Study. J Am Geriatr Soc 53 6 (2005) 935-942
30. Henderson A.S., Easteal S., Jorm A.F., Mackinnon A.J., Korten A.E., Christensen H., et al. Apolipoprotein E allele epsilon 4, dementia, and cognitive decline in a population sample. Lancet 346 (1995) 1387-1390
31. Ivnik R.J., Malec J.F., Smith G.E., Tangalos E.G., Petersen R.C., Kokmen E., et al. Mayo's Older Americans Normative Studies: Updated AVLT norms for ages 56 to 97. The Clinical Neuropsychologist 6 Suppl. (1992) 83-104
32. Kaufmann W.E., Abrams M.T., Chen W., and Reiss A.L. Genotype, molecular phenotype, and cognitive phenotype: Correlations in fragile X syndrome. American Journal of Medicine Genet 83 (1999) 286-295
33. Kokmen E., Naessens J.M., and Offord K.P. A short test of mental status: Description and preliminary results. Mayo Clinic Proceedings 62 (1987) 281-288
34. Lichtman S.W., Seliger G., Tycko B., and Marder K. Apolipoprotein E and functional recovery from brain injury following postacute rehabilitation. Neurology 55 (2000) 1536-1539
35. Lind J., Larsson A., Persson J., Ingvar M., Nilsson L.G., Backman L., et al. Reduced hippocampal volume in non-demented carriers of the apolipoprotein E epsilon4: Relation to chronological age and recognition memory. Neuroscience Letters 396 (2006) 23-27
36. Linn R.T., Wolf P.A., Bachman D.L., Knoefel J.E., Cobb J.L., Belanger A.J., et al. The 'preclinical phase' of probable Alzheimer's disease: A 13-year prospective study of the Framingham cohort. Archives of Neurology 52 (1995) 485-490
37. Mauch D.H., Nagler K., Schumacher S., Goritz C., Muller E.C., Otto A., et al. CNS synaptogenesis promoted by glia-derived cholesterol. Science 294 (2001) 1354-1357
38. Moffat S.D., Szekely C.A., Zonderman A.B., Kabani N.J., and Resnick S.M. Longitudinal change in hippocampal volume as a function of apolipoprotein E genotype. Neurology 55 (2000) 134-136
39. Nobre A.C., Sebestyen G.N., Gitelman D.R., Mesulam M.M., Frackowiak R.S., and Frith C.D. Functional localization of the system for visuospatial attention using positron emission tomography. Brain 120 (1997) 515-533
40. Parasuraman R., Greenwood P.M., and Sunderland T. The apolipoprotein E gene, attention, and brain function. Neuropsychology 16 (2002) 254-274
41. Plassman B.L., Welsh-Bohmer K.A., Bigler E.D., Johnson S.C., Anderson C.V., Helms M.J., et al. Apolipoprotein E epsilon 4 allele and hippocampal volume in twins with normal cognition. Neurology 48 (1997) 985-989
42. Poirier J. Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease. Trends in Neurosciences 17 (1994) 525-530
43. Posner M.I. Orienting of attention. Quarterly Journal of Experimental Psychology 32 (1980) 3-25
44. Posner M.I., Walker J.A., Friderich F.J., and Rafal R.D. Effects of parietal injury on covert orienting of attention. Journal of Neuroscience 4 (1984) 1863-1874
45. Reiman E.M., Caselli R.J., Chen K., Alexander G.E., Bandy D., and Frost J. Declining brain activity in cognitively normal apolipoprotein E epsilon 4 heterozygotes: A foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America 98 (2001) 3334-3339
46. Reiman E.M., Chen K., Alexander G.E., Caselli R.J., Bandy D., Osborne D., et al. Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia. Proceedings of the National Academy of Sciences of the United States of America 101 (2004) 284-289
47. Rogers S.W., Gahring L.C., Collins A.C., and Marks M. Age-related changes in neuronal nicotinic acetylcholine receptor subunit alpha4 expression are modified by long-term nicotine administration. Journal of Neuroscience 18 (1998) 4825-4832
48. Rosen W.G., Terry R.D., Fuld P.A., Katzman R., and Peck A. Pathological verification of ischemic score in differentiation of dementias. Annals of Neurology 7 (1980) 486-488
49. Scarmeas N., and Stern Y. Imaging studies and APOE genotype in persons at risk for Alzheimer's disease. Current Psychiatry Reports 8 (2006) 11-17
50. Small B.J., Fratiglioni L., Viitanen M., Winblad B., and Backman L. The course of cognitive impairment in preclinical Alzheimer disease: Three- and 6-year follow-up of a population-based sample. Archives of Neurology 57 (2000) 839-844
51. Small B.J., Rosnick C.B., Fratiglioni L., and Backman L. Apolipoprotein E and cognitive performance: A meta-analysis. Psychology and Aging 19 (2004) 592-600
52. Smith G.E., Bohac D.L., Waring S.C., Kokmen E., Tangalos E.G., Ivnik R.J., et al. Apolipoprotein E genotype influences cognitive 'phenotype' in patients with Alzheimer's disease but not in healthy control subjects. Neurology 50 (1998) 355-362
53. Teasdale G.M., Murray G.D., and Nicoll J.A. The association between APOE epsilon4, age and outcome after head injury: A prospective cohort study. Brain 128 (2005) 2556-2561
54. Teter B., and Ashford J.W. Neuroplasticity in Alzheimer's disease. Journal of Neuroscience Research 70 (2002) 402-437
55. Wechsler D.A. Wechsler Memory Scale-Revised (1987), Psychological Corporation, New York
56. White F., Nicoll J.A., and Horsburgh K. Alterations in ApoE and ApoJ in relation to degeneration and regeneration in a mouse model of entorhinal cortex lesion. Experimental Neurology 169 (2001) 307-318
57. White F., Nicoll J.A., Roses A.D., and Horsburgh K. Impaired neuronal plasticity in transgenic mice expressing human apolipoprotein E4 compared to E3 in a model of entorhinal cortex lesion. Neurobiology of Disease 8 (2001) 611-625